• Latest Posts

FDA approves BioMarin gene therapy for hemophilia A

The Biotech World is Buzzing: J.P. Morgan’s 2016 Phenomenon Kicks off this Week!

First gene therapy for adults with severe hemophilia approved by EC

BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies

It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?

Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease

ADVERTISEMENT

UniQure’s cure for rare Lysosomal disease ready for phase III trial

The 5 things outside Europe you need to know this week (Samsung $1Bn Biotech IPO, Microbiome blindness, Google Biotech)

ADVERTISEMENT